Table 4

Adverse events (AEs)

Placebo (n=29)EPA-FFA (n=29)
n*%†n%
Diarrhoea10 (9)34.59 (9)31.0
Abdominal pain6 (6)20.79 (8)27.6
Abdominal distension5 (5)17.23 (3)10.3
Upper abdominal pain5 (5)17.26 (6)20.7
Epigastric discomfort5 (5)17.23 (3)10.3
Nausea3 (3)10.39 (9)31.0
Headache5 (5)17.28 (8)27.6
Dizziness——5 (5)17.2
Malaise5 (5)17.23 (3)10.3

  • ↵* n=number of AEs reported during the 6 month treatment period. The figure in parentheses is the number of subjects reporting a particular AE.

  • ↵† The percentage of subjects in each group reporting a given AE.

  • EPA-FFA, eicosapentaenoic acid as the free fatty acid.